Proteomic Biomarker Analytics Markets
Proteomic Analytics is replacing genomics as the new frontier in biotechnology. There is plenty of opportunity and some completely new types of biomarkers are already at work…....
269 pages packed with information
Proteomics is going mainstream. Where genomics couldn’t find all the answers proteomics is stepping up to the plate.
Who will be the Illumina of Proteomics? Will these new biomarkers redefine disease definitions? Will Proteomic Assays displace current Genomic Assays? Find out all about it and more in this comprehensive report.
Proteomic Biomarker Analytics is just finding its feet, but the opportunity is to understand the front line players, the actual proteins and protein complexes, that do the work of managing cellular life. Players are reporting double digit growth. Venture capital is well involved. Learn about this market including the issues and outlooks. This technology could possibly displace most cancer diagnostic protocols AND save money at the same time. The report forecasts the market size out for five years for a number of different market segments.
Our facts and support = Your success.
Assistance in using the information is normally provided without additional charges. The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges.
All report data is available in Excel format on request.
Send an email to us at firstname.lastname@example.org and we will happily email you a FREE copy of SAMPLE PAGES FROM THIS REPORT without any obligation on your part.
Make investment decisions and valuations with confidence using the latest data.
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research.
He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell’s education includes:
B.Sc. (Chemistry) University of BC
M.B.A. (Finance and Policy) University of BC
Market Research - Burke Institute
Finance for Senior Executives - Harvard Business School